Cresset Asset Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $450K | Sell |
9,244
-1,027
| -10% | -$50K | ﹤0.01% | 1102 |
|
|
2025
Q1 | $350K | Sell |
10,271
-4,771
| -32% | -$162K | ﹤0.01% | 1224 |
|
|
2024
Q4 | $592K | Sell |
15,042
-12,037
| -44% | -$474K | ﹤0.01% | 991 |
|
|
2024
Q3 | $1.27M | Sell |
27,079
-3,115
| -10% | -$146K | ﹤0.01% | 1023 |
|
|
2024
Q2 | $1.63M | Buy |
30,194
+14,946
| +98% | +$807K | 0.01% | 798 |
|
|
2024
Q1 | $1.04M | Buy |
15,248
+1,611
| +12% | +$110K | 0.01% | 941 |
|
|
2023
Q4 | $854K | Buy |
13,637
+2,964
| +28% | +$186K | 0.01% | 948 |
|
|
2023
Q3 | $484K | Sell |
10,673
-49
| -0.5% | -$2.22K | ﹤0.01% | 1163 |
|
|
2023
Q2 | $602K | Buy |
+10,722
| New | +$602K | ﹤0.01% | 1050 |
|
|
2022
Q2 | – | Sell |
-3,755
| Closed | -$236K | – | 977 |
|
|
2022
Q1 | $236K | Sell |
3,755
-3,329
| -47% | -$209K | ﹤0.01% | 861 |
|
|
2021
Q4 | $537K | Sell |
7,084
-12,702
| -64% | -$963K | 0.01% | 674 |
|
|
2021
Q3 | $2.21M | Buy |
19,786
+670
| +4% | +$75K | 0.03% | 208 |
|
|
2021
Q2 | $3.1M | Buy |
19,116
+1,513
| +9% | +$245K | 0.04% | 152 |
|
|
2021
Q1 | $2.15M | Buy |
17,603
+5,423
| +45% | +$661K | 0.03% | 168 |
|
|
2020
Q4 | $1.87M | Buy |
12,180
+691
| +6% | +$106K | 0.03% | 168 |
|
|
2020
Q3 | $961K | Buy |
11,489
+4,743
| +70% | +$397K | 0.02% | 236 |
|
|
2020
Q2 | $496K | Buy |
+6,746
| New | +$496K | 0.01% | 343 |
|